Wall Street is Bullish on DexCom (DXCM), Here’s Why

Core Insights - DexCom, Inc. (NASDAQ:DXCM) has shown strong financial performance, exceeding revenue and EPS estimates in Q2 2025, with revenue of $1.16 billion, a 15.21% year-over-year increase, and EPS of $0.48, surpassing expectations by $0.04 [1][2] Financial Performance - The company reported a revenue of $1.16 billion, which is up 15.21% year-over-year and exceeded consensus estimates by $32.49 million [1] - The US revenue segment grew by 15%, while the International segment saw a 7% year-over-year growth [2] Analyst Sentiment - Several analysts have maintained a bullish outlook on DexCom, with price targets indicating significant upside potential; Argus Research set a target of $100, Bernstein at $98, and Piper Sandler also at $100, suggesting a 35.5% upside from current levels [3]